Mayo Alliance Prognostic System (MAPS) Score
Evaluates prognosis of systemic mastocytosis.
Advice
- A higher score is associated with a poorer prognosis.
- Results should be integrated into a comprehensive evaluation to inform management decisions, such as opting for more aggressive treatment strategies when necessary.